RABEPRAKYRL 20 MG 20 TABS

RABEPRAKYRL 20 MG 20 TABS

Description:

RABEPRAKYRL 20 mg 20 tabs is a prescription oral medicine containing rabeprazole sodium, a proton pump inhibitor (PPI) used to reduce excess stomach acid. It is commonly prescribed for the treatment of acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and conditions associated with pathological hypersecretion of gastric acid. By selectively and irreversibly inhibiting the gastric proton pump (H+ / K+ ATPase) in the stomach’s parietal cells, RABEPRAKYRL provides powerful and long-lasting acid suppression, helping relieve heartburn, acid regurgitation, and promote healing of erosions and ulcers.

Indications:

• Treatment of gastroesophageal reflux disease (GERD), including erosive or ulcerative reflux esophagitis.
• Symptomatic relief of heartburn, acid indigestion, and acid regurgitation associated with excess gastric acid.
• Treatment of duodenal ulcers and gastric (stomach) ulcers.
• Maintenance therapy to prevent relapse of healed erosive esophagitis or peptic ulcers, as directed by a physician.
• Conditions of pathological hypersecretion of gastric acid such as Zollinger–Ellison syndrome (under specialist supervision).
• Adjunctive therapy in Helicobacter pylori eradication regimens (in combination with appropriate antibiotics, as prescribed).

Active Ingredients / Key Components:

• Rabeprazole sodium – 20 mg per tablet.
• Excipients: Information on inactive ingredients (such as fillers, binders, colorants, and coating agents) is not available in the provided data. Please refer to the package leaflet for the full excipient list.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not exceed the recommended dose or duration.
• Typical adult dose for GERD or peptic ulcer disease (if prescribed): 20 mg (1 tablet) once daily. Your doctor may adjust the dose and duration based on your condition and response.
• Tablets should be swallowed whole with a glass of water. Do not crush, chew, or split the tablets, as they are usually enteric-coated to protect the active ingredient from stomach acid.
• RABEPRAKYRL can be taken with or without food; however, many clinicians prefer administration before a meal (often in the morning) for optimal acid suppression. Follow your doctor’s specific instructions.
• For Helicobacter pylori eradication, rabeprazole is taken in combination with antibiotics in specific regimens and schedules determined by the physician.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Do not stop treatment abruptly without consulting your doctor, especially if you have been on long-term therapy.

Clinical Benefits:

• Provides potent and sustained reduction of gastric acid secretion by irreversibly inhibiting the proton pump (H+ / K+ ATPase) in stomach parietal cells.
• Helps relieve symptoms of heartburn, acid reflux, and epigastric pain, improving daily comfort and quality of life.
• Promotes healing of erosive esophagitis, duodenal ulcers, and gastric ulcers by maintaining a less acidic environment in the stomach.
• Supports mucosal protection and helps in mucin synthesis, contributing to the repair of the gastrointestinal lining.
• Useful in managing chronic hypersecretory conditions (such as Zollinger–Ellison syndrome) under specialist supervision.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to rabeprazole, other proton pump inhibitors, or any component of the formulation.
• Do not use without medical supervision if you have alarming symptoms such as unintentional weight loss, persistent vomiting, difficulty swallowing, vomiting blood, or black/tarry stools. These may indicate serious gastrointestinal disease requiring further evaluation.
• Long-term use of PPIs has been associated with an increased risk of bone fractures (hip, wrist, spine), vitamin B12 deficiency, hypomagnesemia, and possible increased risk of certain infections (e.g., Clostridioides difficile–associated diarrhea, respiratory infections). Use the lowest effective dose for the shortest duration necessary.
• Caution in patients with severe liver impairment; dose adjustment or closer monitoring may be required. Inform your doctor if you have liver disease.
• May mask symptoms of gastric malignancy. Evaluation for malignancy should be considered in patients with alarm symptoms before starting therapy.
• Use with caution in patients taking drugs affected by gastric pH (e.g., ketoconazole, itraconazole, atazanavir) or drugs with potential interactions. Inform your doctor about all medications and supplements you are taking.
• Consult your doctor before use if pregnant or planning pregnancy. Rabeprazole should only be used during pregnancy if clearly needed and prescribed by a physician.
• Breastfeeding: It is not known whether rabeprazole is excreted in human milk. A decision should be made with your doctor whether to discontinue breastfeeding or discontinue the drug.
• Not intended for self-medication in children unless specifically prescribed by a pediatric specialist.
• Consult your doctor before use if you have osteoporosis, are on long-term corticosteroid therapy, have low magnesium levels, or other chronic medical conditions.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as liver disease, osteoporosis, or electrolyte disturbances.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, flatulence, and dry mouth.
• Less common side effects can include rash, itching, or other hypersensitivity reactions; if you experience swelling of the face, lips, tongue, or throat, difficulty breathing, or severe skin reactions, seek emergency medical attention.
• Long-term use may be associated with vitamin B12 deficiency, low magnesium levels (hypomagnesemia), and increased risk of bone fractures. Symptoms of low magnesium may include muscle cramps, irregular heartbeat, seizures, or fatigue; contact your doctor if these occur.
• Very rare but serious side effects may include severe diarrhea (possibly due to Clostridioides difficile infection), severe liver dysfunction, or interstitial nephritis. Seek medical advice if you develop persistent diarrhea, jaundice, dark urine, or unexplained fatigue.
• If any side effect becomes severe, persistent, or you notice any unusual symptoms, stop taking the medication and consult your healthcare provider promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Strength: 20 mg rabeprazole sodium per tablet.
• Form: Oral tablet.
• Pack size: 20 tablets per pack.
• Intended use: Prescription medicine for acid-related gastrointestinal disorders under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.